Anika Therapeutics to Present at the Rodman & Renshaw Annual Global Investment Conference on September 10 BEDFORD, Mass. --(BUSINESS WIRE)--Aug. 16, 2013-- Anika Therapeutics, Inc. (Nasdaq: ANIK) a leader in products for tissue protection, healing and repair, based on hyaluronic acid (“HA”) technology, today announced that its Chief Executive Officer,  Charles Sherwood , Ph.D., will be presenting at the Rodman & Renshaw Annual  Global Investment Conference  on  Tuesday, September 10, 2013  at  11:40 a.m. ET . The conference is being held at the  Millennium Broadway Hotel  in  New York City .

An audio webcast of the presentation will be available live and may be accessed via the “Investor Relations” section of Anika’s website at www.anikatherapeutics.com. An archive of the presentation also will be available on the website.

About Anika Therapeutics, Inc.

Headquartered in Bedford, Mass., Anika Therapeutics, Inc. develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair. These products are based on hyaluronic acid (HA), a naturally occurring, biocompatible polymer found throughout the body. Anika’s products range from orthopedic/joint health solutions led by Orthovisc®, a treatment for osteoarthritis of the knee; to surgical aids in the anti-adhesion and ophthalmic fields. The company also offers aesthetic dermal fillers for the correction of facial wrinkles. Anika’s Italian subsidiary, Anika Therapeutics S.r.l., provides complementary HA products in orthopedic/joint health and anti-adhesion, as well as therapeutics in areas such as advanced wound treatment and ear, nose and throat care. Its regenerative tissue technology advances Anika’s vision to offer therapeutic products that go beyond pain relief to protect and restore damaged tissue.

Source: Anika Therapeutics, Inc.

Anika Therapeutics, Inc.
Charles H. Sherwood, 781-457-9000
Ph.D., CEO
or
Sylvia Cheung, 781-457-9000
CFO